FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134984157> ?p ?o ?g. }

• W2134984157 endingPage "833" @default.
• W2134984157 startingPage "827" @default.
• W2134984157 abstract "To evaluate the prognostic significance of the neutrophil-to-lymphocyte ratio in patients receiving chemotherapy with docetaxel for castration-resistant prostate cancer.A total of 57 castration-resistant prostate cancer patients treated between 2009 and 2014 were included in the present retrospective study. All patient data, including clinicopathological factors, were assessed. Univariate and multivariate Cox regression models were used to predict overall survival and progression-free survival after chemotherapy initiation.The median overall survival and progression-free survival were determined as 19.0 months (range 1-61 months) and 10.0 months (range 1-56 months), respectively. The cut-off level of the neutrophil-to-lymphocyte ratio was set as the median value of 3.5 among all patients in this study. In Kaplan-Meier analysis, the median overall survival and progression-free survival were shorter in patients with a high neutrophil-to-lymphocyte ratio compared with those with a low neutrophil-to-lymphocyte ratio (15 vs 20 months, P = 0.0125; and 9.5 vs 15 months, P = 0.0132, respectively). The overall survival and progression-free survival periods in patients with a high neutrophil-to-lymphocyte ratio were significantly shorter than those of patients with a low neutrophil-to-lymphocyte ratio (P = 0.0178 and 0.0176, respectively). In the multivariate analysis, a high neutrophil-to-lymphocyte ratio was an independent predictor of overall survival and progression-free survival (hazard ratio 2.728, 95% confidence interval 1.05-7.09, P = 0.039; and hazard ratio 2.376, 95% confidence interval 1.12-5.06, P=0.024, respectively).The present study results suggest that the neutrophil-to-lymphocyte ratio is a useful prognostic factor in patients with castration-resistant prostate cancer treated by docetaxel chemotherapy. These findings might be useful in determining treatment strategies in the future." @default.
• W2134984157 created "2016-06-24" @default.
• W2134984157 creator A5056273616 @default.
• W2134984157 creator A5067275958 @default.
• W2134984157 creator A5070720566 @default.
• W2134984157 creator A5073850979 @default.
• W2134984157 creator A5074384661 @default.
• W2134984157 creator A5078203816 @default.
• W2134984157 creator A5089760587 @default.
• W2134984157 date "2015-06-18" @default.
• W2134984157 modified "2023-10-05" @default.
• W2134984157 title "High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy" @default.
• W2134984157 cites W1541532008 @default.
• W2134984157 cites W1993213090 @default.
• W2134984157 cites W2004973733 @default.
• W2134984157 cites W2050028052 @default.
• W2134984157 cites W2080439368 @default.
• W2134984157 cites W2085458222 @default.
• W2134984157 cites W2091553144 @default.
• W2134984157 cites W2102144390 @default.
• W2134984157 cites W2102996930 @default.
• W2134984157 cites W2103090668 @default.
• W2134984157 cites W2103959341 @default.
• W2134984157 cites W2110534364 @default.
• W2134984157 cites W2119034557 @default.
• W2134984157 cites W2120292596 @default.
• W2134984157 cites W2123526148 @default.
• W2134984157 cites W2128675949 @default.
• W2134984157 cites W2136636834 @default.
• W2134984157 cites W2147775685 @default.
• W2134984157 cites W2148643283 @default.
• W2134984157 cites W2152524140 @default.
• W2134984157 cites W2154361786 @default.
• W2134984157 cites W2158734599 @default.
• W2134984157 cites W2167363836 @default.
• W2134984157 cites W2917015058 @default.
• W2134984157 doi "https://doi.org/10.1111/iju.12839" @default.
• W2134984157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26087772" @default.
• W2134984157 hasPublicationYear "2015" @default.
• W2134984157 type Work @default.
• W2134984157 sameAs 2134984157 @default.
• W2134984157 citedByCount "23" @default.
• W2134984157 countsByYear W21349841572015 @default.
• W2134984157 countsByYear W21349841572016 @default.
• W2134984157 countsByYear W21349841572017 @default.
• W2134984157 countsByYear W21349841572018 @default.
• W2134984157 countsByYear W21349841572019 @default.
• W2134984157 countsByYear W21349841572020 @default.
• W2134984157 countsByYear W21349841572021 @default.
• W2134984157 countsByYear W21349841572022 @default.
• W2134984157 countsByYear W21349841572023 @default.
• W2134984157 crossrefType "journal-article" @default.
• W2134984157 hasAuthorship W2134984157A5056273616 @default.
• W2134984157 hasAuthorship W2134984157A5067275958 @default.
• W2134984157 hasAuthorship W2134984157A5070720566 @default.
• W2134984157 hasAuthorship W2134984157A5073850979 @default.
• W2134984157 hasAuthorship W2134984157A5074384661 @default.
• W2134984157 hasAuthorship W2134984157A5078203816 @default.
• W2134984157 hasAuthorship W2134984157A5089760587 @default.
• W2134984157 hasBestOaLocation W21349841571 @default.
• W2134984157 hasConcept C121608353 @default.
• W2134984157 hasConcept C126322002 @default.
• W2134984157 hasConcept C143998085 @default.
• W2134984157 hasConcept C144301174 @default.
• W2134984157 hasConcept C207103383 @default.
• W2134984157 hasConcept C2776694085 @default.
• W2134984157 hasConcept C2777761686 @default.
• W2134984157 hasConcept C2778963024 @default.
• W2134984157 hasConcept C2780192828 @default.
• W2134984157 hasConcept C2781190966 @default.
• W2134984157 hasConcept C38180746 @default.
• W2134984157 hasConcept C44249647 @default.
• W2134984157 hasConcept C50382708 @default.
• W2134984157 hasConcept C71924100 @default.
• W2134984157 hasConcept C90924648 @default.
• W2134984157 hasConceptScore W2134984157C121608353 @default.
• W2134984157 hasConceptScore W2134984157C126322002 @default.
• W2134984157 hasConceptScore W2134984157C143998085 @default.
• W2134984157 hasConceptScore W2134984157C144301174 @default.
• W2134984157 hasConceptScore W2134984157C207103383 @default.
• W2134984157 hasConceptScore W2134984157C2776694085 @default.
• W2134984157 hasConceptScore W2134984157C2777761686 @default.
• W2134984157 hasConceptScore W2134984157C2778963024 @default.
• W2134984157 hasConceptScore W2134984157C2780192828 @default.
• W2134984157 hasConceptScore W2134984157C2781190966 @default.
• W2134984157 hasConceptScore W2134984157C38180746 @default.
• W2134984157 hasConceptScore W2134984157C44249647 @default.
• W2134984157 hasConceptScore W2134984157C50382708 @default.
• W2134984157 hasConceptScore W2134984157C71924100 @default.
• W2134984157 hasConceptScore W2134984157C90924648 @default.
• W2134984157 hasIssue "9" @default.
• W2134984157 hasLocation W21349841571 @default.
• W2134984157 hasLocation W21349841572 @default.
• W2134984157 hasOpenAccess W2134984157 @default.
• W2134984157 hasPrimaryLocation W21349841571 @default.
• W2134984157 hasRelatedWork W2080756964 @default.
• W2134984157 hasRelatedWork W2361700749 @default.
• W2134984157 hasRelatedWork W2770409748 @default.

• next